Cargando…

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy

Detalles Bibliográficos
Autores principales:	Castle, Dan, Robertson, Neil P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687691/ https://www.ncbi.nlm.nih.gov/pubmed/31372734 http://dx.doi.org/10.1007/s00415-019-09485-9

Ejemplares similares

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis
por: Gaebel, Kathryn, et al.
Publicado: (2010)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Monoclonal antibodies for migraine: an update
por: Castle, Daniel, et al.
Publicado: (2018)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Feyen, Ludger, et al.
Publicado: (2023)

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy
por: Dyer, Wayne B., et al.
Publicado: (2016)

An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
por: Anderson-Smits, Colin, et al.
Publicado: (2023)

Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
por: Layton, J. Bradley, et al.
Publicado: (2023)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis
por: McLauchlan, D., et al.
Publicado: (2020)

Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis
por: Willis, M. D., et al.
Publicado: (2017)

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis
por: Hrastelj, James, et al.
Publicado: (2016)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

Transmissible amyloid protein: evidence from iatrogenic CJD
por: Hu, Mo, et al.
Publicado: (2018)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Deep brain stimulation for dystonia
por: Harding, Katharine E., et al.
Publicado: (2016)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

The consequences of valproate exposure in utero
por: Thomas, Rhys H., et al.
Publicado: (2016)

What can rare variant genetics tell us about cognition and intellectual difficulties?
por: Thomas, Rhys H., et al.
Publicado: (2016)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

The role of TSPO PET in assessing neuroinflammation
por: Crawshaw, Ania A., et al.
Publicado: (2017)

Spontaneous intracranial hypotension: features, diagnosis and management
por: Massey, Tom H., et al.
Publicado: (2021)

Medication-overuse headache: causes, consequences and management
por: Massey, Thomas H., et al.
Publicado: (2021)

Clinical trials for cerebellar ataxia
por: Schroeder, Benjamin E., et al.
Publicado: (2022)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s5jdgg9akfdvdgrj90jkj0pppg